Alcon AG | ALC - Sales Revenues

Stock Price
59.48
Daily Change
-0.36 -0.60%
Monthly
0.13%
Yearly
-24.99%
Q2 Forecast
58.14

Alcon AG reported $2.7B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
AstraZeneca USD 15.5B 313M Dec/2025
Bayer EUR 11.44B 1.78B Dec/2025
Essilor EUR 14.47B 7.6B Dec/2025
Fresenius EUR 5.88B 400M Dec/2025
Fresenius Medical Care EUR 5.07B 180M Dec/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
GRIFOLS EUR 1.98B 110M Dec/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.25B 70M Dec/2025
Novartis USD 13.11B 226M Mar/2026
Philips EUR 5.1B 797M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.24B 60M Mar/2026
Smith & Nephew USD 3.18B 353M Dec/2025
Sonova Holding CHF 1.82B 216.8M Dec/2025
UCB EUR 4.25B 764M Dec/2025